Click a link below to view the mailing archive as if it had been sent to you.
| 2023-01-31 12:15 | | A startup launches with plans to open up a gene and cell therapy bottleneck and more... |
| 2023-01-31 00:15 | | AstraZeneca, Novo Nordisk and Sanofi score 340B-related appeals court win over HHS and more... |
| 2023-01-30 12:15 | | Amgen, navigating 'industry headwinds,' puts 300 commercial jobs on chopping block and more... |
| 2023-01-30 00:15 | | Lilly enters ripe BTK field with quick FDA nod in mantle cell lymphoma and more... |
| 2023-01-27 12:15 | | PBMs likely to be a focus in 118th Congress and more... |
| 2023-01-27 00:15 | | FDA advisers back agency plan to simplify COVID-19 vaccination and more... |
| 2023-01-26 12:15 | | Roche, Boehringer tap biosensor firms for patient studies and more... |
| 2023-01-26 00:15 | | More data, more dollars: Three biotechs post offerings after trial readouts and more... |
| 2023-01-25 12:15 | | Three VCs launch Dimension, a new firm with plans to fuel biotech’s ‘digitization’ and more... |
| 2023-01-25 00:15 | | J&J reiterates 2025 sales goal despite looming Stelara exclusivity loss, global economic challenges and more... |
| 2023-01-24 12:15 | | Bayer’s oncology business looks to collect $10B in sales by 2030, exec says and more... |
| 2023-01-24 00:15 | | mRNA Covid Shots Safe And Effective In Children Ages 5-11, Large Study Finds—Though Vaccine Uptake Remains Low and more... |
| 2023-01-23 12:15 | | FDA considers major shift in COVID vaccine strategy and more... |
| 2023-01-23 00:15 | | Prosecutors: Convicted CEO Elizabeth Holmes is a flight risk and more... |
| 2023-01-20 12:15 | | Disc Medicine pays $10M upfront for monoclonal antibody for rare blood disorder, cancer and more... |
| 2023-01-20 00:15 | | Eli Lilly says U.S. FDA rejects accelerated approval for Alzheimer's drug and more... |
| 2023-01-19 12:15 | | Sun Pharma to purchase Concert Pharmaceuticals for $576M and more... |
| 2023-01-19 00:15 | | How 2 biotechs survived 2022’s rocky market—and why their CEOs see success on the horizon and more... |
| 2023-01-18 12:15 | | Phase 2 attrition jumps amid widespread scale-back in overall clinical trial activity: study and more... |
| 2023-01-18 00:15 | | Luye claims its first FDA approval, for bi-weekly schizophrenia drug and more... |
| 2023-01-17 12:15 | | Pfizer pledges to sell all of its products at cost to poor countries and more... |
| 2023-01-16 12:15 | | Chasing Roche, Merck talks up subcutaneous Keytruda ahead of phase 3 data drop and more... |
| 2023-01-13 12:15 | | Novo Nordisk's GLP-1 for Type II diabetes approved for first-line treatment and more... |
| 2023-01-13 00:15 | | Panbela begins Phase II trial of type 1 diabetes therapy trial and more... |
| 2023-01-12 12:15 | | Did Storms Steal JPM's Thunder? and more... |
| 2023-01-12 00:15 | | JPM23: Takeda tests Bristol Myers, Prime weighs spinoffs and Sanofi faces down a competitor and more... |
| 2023-01-11 12:15 | | Biden team eyes end of Covid emergency declaration and shift in Covid teamBiden team eyes end of Covid emergency declaration and shift in Covid team and more... |
| 2023-01-11 00:15 | | JPM Day 2: Highlights and more... |
| 2023-01-10 12:15 | | BioNTech buys UK AI start-up InstaDeep in £562mn deal and more... |
| 2023-01-10 00:15 | | JPM Day 1: Highlights and more... |
| 2023-01-09 12:15 | | Trio of biotech buyouts jumpstarts J.P. Morgan healthcare meeting and more... |
| 2023-01-09 00:15 | | Italy's Chiesi Farmaceutici to buy Amryt Pharma in a $1.48 billion deal and more... |
| 2023-01-07 00:15 | | FDA approves Alzheimer’s drug from Eisai, Biogen in closely watched decision |
| 2023-01-06 12:15 | | Pfizer pivots from early-stage rare disease R&D, shifting to external innovation and putting assets up for sale and more... |
| 2023-01-06 00:15 | | Ready for takeoff: J&J's consumer health unit Kenvue files for official separation and more... |
| 2023-01-05 12:15 | | FDA starts review of Sanofi, AZ antibody for RSV prevention and more... |
| 2023-01-05 00:15 | | Lilly's Prevail, Capsida partner to develop gene therapies for nervous system diseases and more... |
| 2023-01-04 12:15 | | Moderna makes its first-ever acquisition, buying Japanese DNA manufacturer OriCiro for $85M and more... |
| 2023-01-04 00:15 | | Pharma companies boost drug prices to start year, but hikes lag inflation and more... |
| 2023-01-03 12:15 | | 10 clinical trials to watch in the first half of 2023 and more... |
| 2023-01-03 00:15 | | ADC deals: Mersana engages with Merck, LegoChem and Amgen collaborate and more... |
